first glp-1 drug Medications for Weight Loss New GLP-1 Guidelines for Type

Based on this review, evidence from head-to-head and insulin-comparator trials demonstrates that dual GIP/GLP-1 co-agonism consistently overcomes metabolic plateaus that result from single-pathway therapy, producing superior glycated hemoglobin reduction, bariatric-level weight loss (up to 25.3%), and robust macrovascular and heart failure protection, including a 38% reduction in composite cardiovascular risk among patients with heart failure with preserved ejection fraction (HFpEF)

Supergut CEO Marc Washington on riding the Ozempic wave, the importance of prebiotic fibre, boosting GLP-1, and formulating vegan products.

Notably, patients on GLP-1 RAs exhibited a 195% higher risk of major depression, a 108% increased risk for anxiety, and a 106% elevated risk for suicidal behavior

The first clinical study of an oral small-molecule GLP-1 receptor agonist suggests effective glycemic control and weight loss in patients with type 2 diabetes.

Discussing Pfizer's savvy acquisition of Metsera and critiquing the GLP-1 'gap analysis' many outsiders promote as a reason all the Big Pharmas will be in GLP-1

PROMOTE HEALTHY WEIGHT MANAGEMENT - Premium psyllium husk powder and other ingredients help promote healthy weight management, digestion and provide balanced energy throughout your day